Biomarkers of necrotising enterocolitis

Seminars in Fetal and Neonatal Medicine

Volumn 19, Issue 1, 2014, Pages 33-38

  Ng, Pak Cheung ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Biomarkers; Infants; Necrotising enterocolitis

Indexed keywords

ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; CHEMOKINE; CYTOKINE; MEMBRANE ANTIGEN; MICRORNA; VOLATILE ORGANIC COMPOUND;

DISEASE MARKER; HUMAN; METHODOLOGY; MICROBIOME; NECROTIZING ENTEROCOLITIS; PREMATURITY; REVIEW; STUDY DESIGN;

BIOMARKERS; INFANTS; NECROTISING ENTEROCOLITIS;

BIOLOGICAL MARKERS; ENTEROCOLITIS, NECROTIZING; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE;

EID: 84891662696     PISSN: 1744165X     EISSN: 18780946     Source Type: Journal    
DOI: 10.1016/j.siny.2013.09.002     Document Type: Review

References (62)

1. Neu J., Walker W.A. Necrotizing enterocolitis. N Engl J Med 2011, 364:255-264.
2. Lin P.W., Stoll B.J. Necrotising enterocolitis. Lancet 2006, 368:1271-1283.
3. Holman R.C., Stoll B.J., Curns A.T., Yorita K.L., Steiner C.A., Schonberger L.B. Necrotising enterocolitis hospitalisations among neonates in the United States. Paediatr Perinat Epidemiol 2006, 20:498-506.
4. Guillet R., Stoll B.J., Cotten C.M., Gantz M., McDonald S., Poole W.K., et al. Association of H2-blocker therapy and higher incidence of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2006, 117:e137-e142.
5. Hintz S.R., Kendrick D.E., Stoll B.J., Vohr B.R., Fanaroff A.A., Donovan E.F., et al. Neurodevelopmental and growth outcomes of extremely low birth weight infants after necrotizing enterocolitis. Pediatrics 2005, 115:696-703.
6. Salhab W.A., Perlman J.M., Silver L., Sue Broyles R. Necrotizing enterocolitis and neurodevelopmental outcome in extremely low birth weight infants < 1000 g. J Perinatol 2004, 24:534-540.
7. Ng P.C., Chan K.Y.Y., Poon T.C.W. Biomarkers for prediction of diagnosis of necrotizing enterocolitis. Clin Perinatol 2013, 40:149-159.
8. Ng P.C., Lee C.H., Wong S.P., Lam H.S., Liu F.Y., So K.W., et al. High-dose oral erythromycin decreased the incidence of parenteral nutrition-associated cholestasis (PNAC) in preterm infants with gastrointestinal dysmotility: a randomized double-blind controlled study. Gastroenterology 2007, 132:1726-1739.
9. Ng E.W., Poon T.C., Lam H.S., Cheung H.M., Ma T.P., Chan K.Y., et al. Gut-associated biomarkers L-FABP, I-FABP, and TFF3 and LIT score for diagnosis of surgical necrotizing enterocolitis in preterm infants. Ann Surg 2013, [Epub ahead of print].
10. Kosloske A.M. Indications for operation in necrotizing enterocolitis revisited. J Pediatr Surg 1994, 29:663-666.
11. Faingold R., Daneman A., Tomlinson G., Babyn P.S., Manson D.E., Mohanta A., et al. Necortizing enterocolitis: assessment of bowel viability with color Doppler US. Radiology 2005, 235:587-594.
12. Ng P.C., Cheng S.H., Chui K.M., Fok T.F., Wong M.Y., Wong W., et al. Diagnosis of late onset neonatal sepsis with cytokines, adhesion molecule, and C-reactive protein in preterm very low birth weight infants. Arch Dis Child Fetal Neonatal Ed 1997, 77:221-227.
13. Pourcyrous M., Korones S.B., Yang W., Boulden T.F., Bada H.S. C-reactive protein in the diagnosis, management and prognosis of neonatal necrotizing enterocolitis. Pediatrics 2005, 116:1064-1069.
14. Centinkaya M., Ozkan H., Koksal N., Akaci O., Ozgür T. Comparison of the efficacy of serum amyloid A, C-reactive protein, and procalcitonin in the diagnosis and follow-up of necrotizing enterocolitis in premature infants. J Pediatr Surg 2011, 46:1482-1489.
15. Cetinkaya M., Ozkan H., Koksal N., Akaci O., Ozgur T. The efficacy of serial serum amyloid A measurements for diagnosis and follow-up of necrotizing enterocolitis in premature infants. Pediatr Surg Int 2010, 26:835-841.
16. Ng P.C., Ang I.L., Chiu R.W., Li K., Lam H.S., Wong R.P., et al. Host-response biomarkers for diagnosis of late-onset septicemia and necrotizing enterocolitis in preterm infants. J Clin Invest 2010, 120:2989-3000.
17. Turner D., Hammerman C., Rudensky B., Schlesinger Y., Wine E., Muise A., et al. Low levels of procalcitonin during episodes of necrotizing enterocolitis. Dig Dis Sci 2007, 52:2972-2976.
18. Tayman C., Tonbul A., Kahveci H., Uysal S., Koseoǧlu B., Tatli M.M., et al. C5a, a complement activation product, is a useful marker in predicting the severity of necrotizing enterocolitis. Tohoku J Exp Med 2011, 224:143-150.
19. Richir M.C., Siroen M.P., van Elburg R.M., Fetter W.P., Quik F., Nijveldt R.J., et al. Low plasma concentrations of arginine and asymmetric dimethylarginine in premature infants with necrotizing enterocolitis. Br J Nutr 2007, 97:906-911.
20. Sharma R., Tepas J.J., Hudak M.L., Mollitt D.L., Wludyka P.S., Teng R.J., et al. Neonatal gut barrier and multiple organ failure: role of endotoxin and proinflammatory cytokines in sepsis and necrotizing enterocolitis. J Pediatr Surg 2007, 42:454-461.
21. Rabinowitz S.S., Dzakpasu P., Piecuch S., Leblanc P., Valencia G., Kornecki E. Platelet-activating factor in infants at risk for necrotizing enterocolitis. J Pediatr 2001, 138:81-86.
22. Khoo A.K., Hall N.J., Alexander N., Evennett N.J., Pierro A., Eaton S. Plasma soluble e-selectin in necrotizing enterocolitis. Eur J Pediatr Surg 2008, 18:419-422.
23. Chaaban H., Shin M., Sirya E., Lim Y.P., Caplan M., Padbury J.F. Inter-alpha inhibitor protein level in neonates predicts necrotizing enterocolitis. J Pediatr 2010, 157:757-761.
24. Terrin G., Passariello A., De Curtis M., Paludetto R. Berni Canani R. S100A8/A9 protein as a marker for early diagnosis of necrotising enterocolitis in neonates. Arch Dis Child 2012, 97:1102.
25. Gounaris A., Alexiou N., Costalos C., Daniilidou M., Frangou E., Konstandellou E. Gut hormone concentrations in preterm infants with necrotizing enterocolitis. Acta Paediatr 1997, 86:762-763.
26. Ng P.C., Li K., Chui K.M., Leung T.F., Wong R.P., Chu W.C., et al. IP-10 is an early diagnostic marker for identification of late-onset bacterial infection in preterm infants. Pediatr Res 2007, 61:93-98.
27. Ng P.C., Li K., Leung T.F., Wong R.P., Li G., Chui K.M., et al. Early prediction of sepsis-induced disseminated intravascular coagulation with interleukin-10, interleukin-6, and RANTES in preterm infants. Clin Chem 2006, 52:1181-1189.
28. Ng P.C., Li K., Wong R.P., Chui K., Wong E., Li G., et al. Proinflammatory and anti-inflammatory cytokine responses in preterm infants with systemic infections. Arch Dis Child Fetal Neonatal Ed 2003, 88:209-213.
29. Lam H.S., Wong S.P., Cheung H.M., Chu W.C., Wong R.P., Chui K.M., et al. Early diagnosis of intra-abdominal inflammation and sepsis by neutrophil CD64 expression in newborns. Neonatology 2011, 99:118-124.
30. Ng P.C., Li K., Wong R.P., Chui K.M., Wong E., Fok T.F. Neutrophil CD64 expression: a sensitive diagnostic marker for late-onset nosocomial infection in very low birth weight infants. Pediatr Res 2002, 51:296-303.
31. Bhandari V., Wang C., Rinder C., Rinder H. Hematologic profile of sepsis in neonates: neutrophil CD64 as a diagnostic marker. Pediatrics 2008, 121:129-134.
32. Turunen R., Andersson S., Nupponen I., Kautiainen H., Siitonen S., Repo H. Increased CD11b-density on circulating phagocytes as an early sign of late-onset sepsis in extremely low-birth-weight infants. Pediatr Res 2005, 57:270-275.
33. Ng P.C., Lam H.S. Biomarkers for late-onset neonatal sepsis: Cytokines and beyond. Clin Perinatol 2010, 37:599-610.
34. Chan K.Y., Leung F.W., Lam H.S., Tam Y.H., To K.F., Cheung H.M., et al. Immunoregulatory protein profiles of necrotizing enterocolitis versus spontaneous intestinal perforation in preterm infants. PLoS ONE 2012, 7:e36977.
35. Carroll D., Corfield A., Spicer R., Cairns P. Faecal calprotectin concentrations and diagnosis of necrotizing enterocolitis. Lancet 2003, 361:310-311.
36. Josefsson S., Bunn S.K., Domellof M. Fecal calprotectin in very low birth weight infants. J Pediatr Gastroenterol Nutr 2007, 44:407-413.
37. Campeotto F., Baldassarre M., Butel M.J., Viallon V., Nganzali F., Soulaines P., et al. Fecal calprotectin: Cutoff values for identifying intestinal distress in preterm infants. J Pediatr Gastroenterol Nutr 2009, 48:507-510.
38. Thuijls G., Derikx J.P., van Wijck K., Zimmermann L.J., Degraeuwe P.L., Mulder T.L., et al. Non-invasive markers for early diagnosis and determination of the severity of necrotizing enterocolitis. Ann Surg 2010, 251:1174-1180.
39. Nisson A.C., van Gils C.E., Menhure P.P., Van den Neucker A.M., van der Hoeven M.A., Forget P.P. Fecal calprotectin in healthy term and preterm infants. J Pediatr Gastroenterol Nutr 2004, 38:107-108.
40. Zoppelli L., Guttel C., Bittrich H.J., Andree C., Wirth S., Jenke A. Fecal calprotectin concentrations in premature infants have a lower limit and show postnatal and gestational age dependence. Neonatology 2012, 102:68-74.
41. Selimoglu M.A., Temel I., Yildirim C., Ozyalin F., Aktas M., Karabiber H. The role of fecal calprotectin and lactoferrin in the diagnosis of necrotizing enterocolitis. Pediatr Crit Care Med 2012, 13:452-454.
42. Dabritz J., Jenke A., Wirth S., Foell D. Fecal phagocyte-specific S100A12 for diagnosing necrotizing enterocolitis. J Pediatr 2012, 162:1059-1064.
43. Chu A., Hageman J.R., Caplan M.S. Necrotizing enterocolitis: Predictive markers and preventive strategies. NeoReviews 2013, 14:e113-e119.
44. Derikx J.P., Evennett N.J., Degraeuwe P.L., Mulder T.L., van Bijnen A.A., van Heurn L.W., et al. Urine based detection of intestinal mucosal cell damage in neonates with suspected necrotizing enterocolitis. Gut 2007, 56:1473-1475.
45. Mannoia K., Boskovic D.S., Slater L., Plank M.S., Angeles D.M., Gollin G. Necrotizing enterocolitis is associated with neonatal intestinal injury. J Pediatr Surg 2011, 46:81-85.
46. Evennett N.J., Hall N.J., Pierro A., Eaton S. Urinary intestinial fatty acid-binding protein concentration predicts extent of disease in necrotizing enterocolitis. J Pediatr Surg 2010, 45:735-740.
47. Edelson M.B., Sonnino R.E., Bagwell C.E., Lieberman J.M., Marks W.H., Rozycki H.J. Plasma intestinal fatty acid binding protein in neonates with necrotizing enterocolitis: A pilot study. J Pediatr Surg 1999, 34:1453-1457.
48. Aydemir C., Dilli D., Oguz S.S., Ulu H.O., Uras N., Erdeve O., et al. Serum intestinal fatty acid binding protein level for early diagnosis and prediction of severity of necrotizing enterocolitis. Early Hum Dev 2011, 87:659-661.
49. Perrone S., Tataranno M.L., Negro S., Cornacchione S., Longini M., Proietti F., et al. May oxidative stress biomarkers in cord blood predict the occurrence of necrotizing enterocolitis in preterm infants?. J Matern Fetal Neonatal Med 2012, 25(suppl 1):128-131.
50. Wu F., Zhang S., Dassopoulos T., Harris M.L., Bayless T.M., Meltzer S.J., et al. Identification of microRNAs associated with ileal and colonic Crohn's disease. Inflamm Bowel Dis 2010, 16:1729-1738.
51. Vasilescu C., Rossi S., Shimizu M., Tudor S., Veronese A., Ferracin M., et al. MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis. PLoS One 2009, 4:e7405.
52. Probert C.S.J., Ahmed I., Khalid T., Johnson E., Smith S., Ratcliffe N. Volatile organic compounds as diagnostic biomarkers in gastrointestinal and liver diseases. J Gastrointestin Liver Dis 2009, 18:337-343.
53. De Lacy Costello B., Ak Ewer, Garner C.E., Probert C.S.J., Ratcliffe N.M., Smith S. An analysis of volatiles in the headspace of the faeces of neonates. J Breath Res 2008, 2:037023.
54. Garner C.E., Ewer A.K., Elasouad K., Power F., Greenwood R., Ratcliffe N.M., et al. Analysis of faecal volatile organic compounds in preterm infants who develop necrotizing enterocolitis: a pilot study. J Pediatr Gastroenterol Nutr 2009, 49:559-565.
55. Mai V., Young C.M., Ukhanova M., Wang X., Sun Y., Casella G., et al. Fecal microbiota in premature infants prior to necrotizing enterocolitis. PLoS ONE 2011, 6:e20647.
56. Smith B., Bodé S., Petersen B.L., Jensen T.K., Pipper C., Kloppenborg J., et al. Community analysis of bacteria colonizing intestinal tissue of neonates with necrotizing enterocolitis. BMC Microbiol 2011, 11:73.
57. Prencipe G., Azzari C., Moriondo M., Devito R., Inglese R., Pezzullo M., et al. Association between mannose-binding lectin gene polymorphisms and necrotizing enterocolitis in preterm infants. J Pediatr Gastroenterol Nutr 2012, 55:160-165.
58. Treszl A., Heninger A., Kalman A., Schuler A., Tulassay T., Vasarhelyi B. Low prevalence of IL-4 receptor alpha-chain gene G variant in very-low-birth-weight infants with necrotizing enterocolitis. J Pediatr Surg 2003, 38:1374-1378.
59. Heninger E., Treszl A., Kocsis I., Derfalvi B., Tulassay T., Vasarhelyi B. Genetic variants of the interleukin-18 promoter region (-607) influence the course of necrotizing enterocolitis in very low birth weight neonates. Eur J Pediatr 2002, 161:410-411.
60. Sampath V., Le M., Lane L., Patel A.L., Cohen J.D., Simpson P.M., et al. The NFKB1 (g.-24519delATTG) variant is associated with necrotizing enterocolitis (NEC) in premature infants. J Surg Res 2011, 169:e51-e57.
61. Moonen R.M., Paulussen A.D., Souren N.Y., Kessels A.G., Rubio-Gozalbo M.E., Villamor E. Carbamoyl phosphate synthetase polymorphisms as a risk factor for necrotizing enterocolitis. Pediatr Res 2007, 62:188-190.
62. Ng P.C., Lam H.S. Biomarkers in neonatology: The next generation of tests. Neonatology 2012, 102:145-151.